HAVN Life Sciences Inc. (HAVLF)

HAVN Life Sciences Balance Sheet

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020
Period Ending	Jan 31, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Cash & Equivalents	0.01	1.06	9.4	1.62
Cash & Short-Term Investments	0.01	1.06	9.4	1.62
Cash Growth	-98.34%	-88.77%	481.43%	-
Accounts Receivable	0.27	0.15	-	-
Other Receivables	0.02	0.17	0.21	-
Receivables	0.29	0.32	0.21	0.25
Inventory	1.05	1.15	0.36	-
Prepaid Expenses	0.02	0.22	0.64	0.08
Total Current Assets	1.38	2.75	10.61	1.94
Property, Plant & Equipment	0	0.36	0.68	-
Other Intangible Assets	-	0.93	2.93	-
Other Long-Term Assets	-	0.02	0.02	-
Total Assets	1.38	4.06	14.24	1.94
Accounts Payable	0.47	0.32	0.53	0.04
Accrued Expenses	0.05	0.21	0.05	-
Current Portion of Leases	-	0.08	0.13	-
Total Current Liabilities	0.51	0.61	0.71	0.04
Long-Term Leases	-	0.31	0.33	-
Total Liabilities	0.54	0.92	1.04	0.04
Common Stock	51.04	49.15	37	1.92
Additional Paid-In Capital	0.59	0.58	0.51	-
Retained Earnings	-57.21	-52.86	-30.42	-0.04
Comprehensive Income & Other	6.42	6.28	6.12	0.02
Shareholders' Equity	0.84	3.14	13.2	1.9
Total Liabilities & Equity	1.38	4.06	14.24	1.94
Total Debt	0.03	0.39	0.46	-
Net Cash (Debt)	-0.01	0.67	8.95	1.62
Net Cash Growth	-	-92.55%	453.21%	-
Net Cash Per Share	-0.00	0.16	4.57	15.54
Filing Date Shares Outstanding	14.74	5.79	4.13	0.58
Total Common Shares Outstanding	14.74	5.09	3.59	0.55
Working Capital	0.86	2.14	9.9	1.9
Book Value Per Share	0.06	0.62	3.68	3.46
Tangible Book Value	0.84	2.21	10.27	1.9
Tangible Book Value Per Share	0.06	0.43	2.86	3.46
Machinery	0.2	0.2	0.2	-
Leasehold Improvements	0.13	0.13	0.03	-

Updated Apr 4, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.